Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Dash, A; Gilliland, DG
   Molecular genetics of acute myeloid leukaemia
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   A. Dash e D.G. Gilliland, "Molecular genetics of acute myeloid leukaemia", BEST P R C, 14(1), 2001, pp. 49-64
2. Hauksdottir, H; Privalsky, ML
   DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia
   CELL GROWTH & DIFFERENTIATION
   
   H. Hauksdottir e M.L. Privalsky, "DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia", CELL GROWTH, 12(2), 2001, pp. 85-98
3. Pandolfi, PP
   Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia
   HUMAN MOLECULAR GENETICS
   
   P.P. Pandolfi, "Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia", HUM MOL GEN, 10(7), 2001, pp. 769-775
4. Pandolfi, PP
   In vivo analysis of the molecular genetics of acute promyelocytic leukemia
   ONCOGENE
   
   P.P. Pandolfi, "In vivo analysis of the molecular genetics of acute promyelocytic leukemia", ONCOGENE, 20(40), 2001, pp. 5726-5735
5. Tobal, K; Moore, H; Macheta, M; Yin, JAL
   Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RAR alpha transcripts with a sensitive competitive RT-PCR method
   LEUKEMIA
   
   K. Tobal et al., "Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RAR alpha transcripts with a sensitive competitive RT-PCR method", LEUKEMIA, 15(7), 2001, pp. 1060-1065
6. Visani, G; Buonamici, S; Malagola, M; Isidori, A; Piccaluga, PP; Martinelli, G; Ottaviani, E; Grafone, T; Baccarani, M; Tura, S
   Pulsed ATRA as single therapy restores long-term remission in PML-RAR alpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study
   LEUKEMIA
   
   G. Visani et al., "Pulsed ATRA as single therapy restores long-term remission in PML-RAR alpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study", LEUKEMIA, 15(11), 2001, pp. 1696-1700
7. Gameiro, P; Vieira, S; Carrara, P; Silva, AL; Diamond, J; de Sousa, AB; Mehta, AB; Prentice, HG; Guimaraes, JE; Hoffbrand, AV; Foroni, L; Parreira, A
   The PML-RAR alpha transcript in long-term follow-up of acute promyelocyticleukemia patients
   HAEMATOLOGICA
   
   P. Gameiro et al., "The PML-RAR alpha transcript in long-term follow-up of acute promyelocyticleukemia patients", HAEMATOLOG, 86(6), 2001, pp. 577-585
8. Torok, M; Etkin, LD
   Two B or not two B? Overview of the rapidly expanding B-box family of proteins
   DIFFERENTIATION
   
   M. Torok e L.D. Etkin, "Two B or not two B? Overview of the rapidly expanding B-box family of proteins", DIFFERENTIA, 67(3), 2001, pp. 63-71
9. Wu, WS; Vallian, S; Seto, E; Yang, WM; Edmondson, D; Roth, S; Chang, KS
   The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases
   MOLECULAR AND CELLULAR BIOLOGY
   
   W.S. Wu et al., "The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases", MOL CELL B, 21(7), 2001, pp. 2259-2268
10. Burmeister, T; Thiel, E
    Molecular genetics in acute and chronic leukemias
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    
    T. Burmeister e E. Thiel, "Molecular genetics in acute and chronic leukemias", J CANC RES, 127(2), 2001, pp. 80-90
11. Jansen, JH; Lowenberg, B
    Acute promyelocytic leukemia with a PLZF-RAR alpha fusion protein
    SEMINARS IN HEMATOLOGY
    
    J.H. Jansen e B. Lowenberg, "Acute promyelocytic leukemia with a PLZF-RAR alpha fusion protein", SEM HEMATOL, 38(1), 2001, pp. 37-41
12. Boisvert, FM; Kruhlak, MJ; Box, AK; Hendzel, MJ; Bazett-Jones, DP
    The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body
    JOURNAL OF CELL BIOLOGY
    
    F.M. Boisvert et al., "The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body", J CELL BIOL, 152(5), 2001, pp. 1099-1106
13. Jurcic, JG; Nimer, SD; Scheinberg, DA; DeBlasio, T; Warrell, RP; Miller, WH
    Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia
    BLOOD
    
    J.G. Jurcic et al., "Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia", BLOOD, 98(9), 2001, pp. 2651-2656
14. Douer, D
    Transcription therapy for acute promyelocytic leukaemia
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    D. Douer, "Transcription therapy for acute promyelocytic leukaemia", EXPERT OP I, 9(2), 2000, pp. 329-346
15. Jurcic, JG; DeBlasio, T; Dumont, L; Yao, TJ; Scheinberg, DA
    Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia
    CLINICAL CANCER RESEARCH
    
    J.G. Jurcic et al., "Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia", CLIN CANC R, 6(2), 2000, pp. 372-380
16. Johnson, AC; Murphy, BA; Matelis, CM; Rubinstein, Y; Piebenga, EC; Akers, LM; Neta, G; Vinson, C; Birrer, M
    Activator protein-1 mediates induced but not basal epidermal growth factorreceptor gene expression
    MOLECULAR MEDICINE
    
    A.C. Johnson et al., "Activator protein-1 mediates induced but not basal epidermal growth factorreceptor gene expression", MOL MED, 6(1), 2000, pp. 17-27
17. Hofmann, WK; Kell, WJ; Fenaux, P; Castaigne, S; Ganser, A; Chomienne, C; Burnett, R; Kowal, C; Hoelzer, D; Burnett, AK
    Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study
    LEUKEMIA
    
    W.K. Hofmann et al., "Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study", LEUKEMIA, 14(9), 2000, pp. 1583-1588
18. Van der Weyden, L; Rakyan, V; Luttrell, BM; Morris, MB; Conigrave, AD
    Extracellular ATP couples to cAMP generation and granulocytic differentiation in human NB4 promyelocytic leukaemia cells
    IMMUNOLOGY AND CELL BIOLOGY
    
    L. Van der Weyden et al., "Extracellular ATP couples to cAMP generation and granulocytic differentiation in human NB4 promyelocytic leukaemia cells", IMM CELL B, 78(5), 2000, pp. 467-473
19. Meyers, S; Hiebert, SW
    Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia
    JOURNAL OF CELLULAR BIOCHEMISTRY
    
    S. Meyers e S.W. Hiebert, "Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia", J CELL BIOC, 2000, pp. 93-98
20. Ruggero, D; Wang, ZG; Pandolfi, PP
    The puzzling multiple lives of PML and its role in the genesis of cancer
    BIOESSAYS
    
    D. Ruggero et al., "The puzzling multiple lives of PML and its role in the genesis of cancer", BIOESSAYS, 22(9), 2000, pp. 827-835
21. Stock, AD; Dennis, TR; Spallone, PA
    Precise localization by microdissection/reverse ISH and FISH of the t(15;17)(q24;q21.1) chromosomal breakpoints associated with acute promyelocytic leukemia
    CANCER GENETICS AND CYTOGENETICS
    
    A.D. Stock et al., "Precise localization by microdissection/reverse ISH and FISH of the t(15;17)(q24;q21.1) chromosomal breakpoints associated with acute promyelocytic leukemia", CANC GENET, 119(1), 2000, pp. 15-17
22. Boisvert, FM; Hendzel, MJ; Bazett-Jones, DP
    Promyelocytic leukemia (PML) nuclear bodies are protein structures that donot accumulate RNA
    JOURNAL OF CELL BIOLOGY
    
    F.M. Boisvert et al., "Promyelocytic leukemia (PML) nuclear bodies are protein structures that donot accumulate RNA", J CELL BIOL, 148(2), 2000, pp. 283-292
23. Redner, RL; Chen, JD; Rush, EA; Li, H; Pollock, SL
    The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties
    BLOOD
    
    R.L. Redner et al., "The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties", BLOOD, 95(8), 2000, pp. 2683-2690
24. Kogan, SC; Hong, SH; Shultz, DB; Privalsky, ML; Bishop, JM
    Leukemia initiated by PMLRAR alpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable
    BLOOD
    
    S.C. Kogan et al., "Leukemia initiated by PMLRAR alpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable", BLOOD, 95(5), 2000, pp. 1541-1550
25. Doucas, V
    The promyelocytic (PML) nuclear compartment and transcription control
    BIOCHEMICAL PHARMACOLOGY
    
    V. Doucas, "The promyelocytic (PML) nuclear compartment and transcription control", BIOCH PHARM, 60(8), 2000, pp. 1197-1201
26. Behre, G; Zhang, P; Zhang, DE; Tenen, DG
    Analysis of the modulation of transcriptional activity in myelopoiesis andleukemogenesis
    METHODS-A COMPANION TO METHODS IN ENZYMOLOGY
    
    G. Behre et al., "Analysis of the modulation of transcriptional activity in myelopoiesis andleukemogenesis", METHODS, 17(3), 1999, pp. 231-237
27. Arnould, C; Philippe, C; Bourdon, V; Gregoire, MJ; Berger, R; Jonveaux, P
    The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia
    HUMAN MOLECULAR GENETICS
    
    C. Arnould et al., "The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia", HUM MOL GEN, 8(9), 1999, pp. 1741-1749
28. Koken, MHM; Daniel, MT; Gianni, M; Zelent, A; Licht, J; Buzyn, A; Minard, P; Degos, L; Varet, B; de The, H
    Retinoic acid, but not arsenic trioxide, degrades the PLZF/RAR alpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient
    ONCOGENE
    
    M.H.M. Koken et al., "Retinoic acid, but not arsenic trioxide, degrades the PLZF/RAR alpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient", ONCOGENE, 18(4), 1999, pp. 1113-1118
29. Kogan, SC; Bishop, JM
    Acute promyelocytic leukemia: from treatment to genetics and back
    ONCOGENE
    
    S.C. Kogan e J.M. Bishop, "Acute promyelocytic leukemia: from treatment to genetics and back", ONCOGENE, 18(38), 1999, pp. 5261-5267
30. Hummel, JL; Wells, RA; Dube, ID; Licht, JD; Kamel-Reid, S
    Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia
    ONCOGENE
    
    J.L. Hummel et al., "Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia", ONCOGENE, 18(3), 1999, pp. 633-641
31. Osman, Y; Takahashi, M; Zheng, Z; Toba, K; Liu, A; Furukawa, T; Narita, M; Aizawa, Y; Koike, T; Shibata, A
    Dendritic cells stimulate the expansion of PML-RAR alpha specific cytotoxic T-lymphocytes: Its applicability for antileukemia immunotherapy
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    
    Y. Osman et al., "Dendritic cells stimulate the expansion of PML-RAR alpha specific cytotoxic T-lymphocytes: Its applicability for antileukemia immunotherapy", J EXP CL C, 18(4), 1999, pp. 485-492
32. Lin, RJ; Egan, DA; Evans, RM
    Molecular genetics of acute promyelocytic leukemia
    TRENDS IN GENETICS
    
    R.J. Lin et al., "Molecular genetics of acute promyelocytic leukemia", TRENDS GEN, 15(5), 1999, pp. 179-184
33. Doucas, V; Tini, M; Egan, DA; Evans, RM
    Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    V. Doucas et al., "Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling", P NAS US, 96(6), 1999, pp. 2627-2632
34. Geller, RB; Dix, SP
    Oral chemotherapy agents in the treatment of leukaemia
    DRUGS
    
    R.B. Geller e S.P. Dix, "Oral chemotherapy agents in the treatment of leukaemia", DRUGS, 58, 1999, pp. 109-118
35. Jansen, JH; de Ridder, MC; Geertsma, WMC; Erpelinck, CAJ; van Lom, K; Smit, EME; Slater, R; van der Reijden, BA; de Greef, GE; Sonneveld, P; Lowenberg, B
    Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor
    BLOOD
    
    J.H. Jansen et al., "Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor", BLOOD, 94(1), 1999, pp. 39-45
36. Edwards, RH; Wasik, MA; Finan, J; Rodriguez, R; Moore, J; Kamoun, M; Rennert, H; Bird, J; Nowell, PC; Salhany, KE
    Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia
    AJCP. American journal of clinical pathology
    
    R.H. Edwards et al., "Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia", AM J CLIN P, 112(6), 1999, pp. 819-827
37. Hussey, CE; Lyon, E; Millson, A; Lay, MJ; Wittwer, CT; Segal, GH
    A rapid practical RT-PCR-based approach for the detection of the PML/RARalpha fusion transcript in acute promyelocytic leukemia
    AJCP. American journal of clinical pathology
    
    C.E. Hussey et al., "A rapid practical RT-PCR-based approach for the detection of the PML/RARalpha fusion transcript in acute promyelocytic leukemia", AM J CLIN P, 112(2), 1999, pp. 256-262
38. GABOLI M; GANDINI D; DELVA L; WANG ZG; PANDOLFI PP
    ACUTE PROMYELOCYTIC LEUKEMIA AS A MODEL FOR CROSS-TALK BETWEEN INTERFERON AND RETINOIC ACID PATHWAYS - FROM MOLECULAR-BIOLOGY TO CLINICAL-APPLICATIONS
    Leukemia & lymphoma
    
    M. Gaboli et al., "ACUTE PROMYELOCYTIC LEUKEMIA AS A MODEL FOR CROSS-TALK BETWEEN INTERFERON AND RETINOIC ACID PATHWAYS - FROM MOLECULAR-BIOLOGY TO CLINICAL-APPLICATIONS", Leukemia & lymphoma, 30(1-2), 1998, pp. 11
39. NASONBURCHENAL K; TAKLE G; PACE U; FLYNN S; ALLOPENNA J; MARTIN P; GEORGE ST; GOLDBERG AR; DMITROVSKY E
    TARGETING THE PML RAR-ALPHA TRANSLOCATION PRODUCT TRIGGERS APOPTOSIS IN PROMYELOCYTIC LEUKEMIA-CELLS/
    Oncogene
    
    K. Nasonburchenal et al., "TARGETING THE PML RAR-ALPHA TRANSLOCATION PRODUCT TRIGGERS APOPTOSIS IN PROMYELOCYTIC LEUKEMIA-CELLS/", Oncogene, 17(14), 1998, pp. 1759-1768
40. FAGIOLI M; ALCALAY M; TOMASSONI L; FERRUCCI PF; MENCARELLI A; RIGANELLI D; GRIGNANI F; POZZAN T; NICOLETTI I; GRIGNANI F; PELICCI PG
    COOPERATION BETWEEN THE RING-B2 AND COILED-COIL DOMAINS OF PML IS NECESSARY FOR ITS EFFECTS ON CELL-SURVIVAL(B1)
    Oncogene
    
    M. Fagioli et al., "COOPERATION BETWEEN THE RING-B2 AND COILED-COIL DOMAINS OF PML IS NECESSARY FOR ITS EFFECTS ON CELL-SURVIVAL(B1)", Oncogene, 16(22), 1998, pp. 2905-2913
41. LE XF; VALLIAN S; MU ZM; HUNG MC; CHANG KS
    RECOMBINANT PML ADENOVIRUS SUPPRESSES GROWTH AND TUMORIGENICITY OF HUMAN BREAST-CANCER CELLS BY INDUCING G1 CELL-CYCLE ARREST AND APOPTOSIS
    Oncogene
    
    X.F. Le et al., "RECOMBINANT PML ADENOVIRUS SUPPRESSES GROWTH AND TUMORIGENICITY OF HUMAN BREAST-CANCER CELLS BY INDUCING G1 CELL-CYCLE ARREST AND APOPTOSIS", Oncogene, 16(14), 1998, pp. 1839-1849
42. Pulsoni, A; Stazi, A; Cotichini, R; Allione, B; Cerri, R; Di Bona, E; Nosari, AM; Pagano, L; Recchia, A; Ribersani, M; Rocchi, L; Veneri, D; Visani, G; Mandelli, F; Mele, A
    Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    A. Pulsoni et al., "Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia", EUR J HAEMA, 61(5), 1998, pp. 327-332
43. TESTA U; GRIGNANI F; HASSAN HJ; ROGAIA D; MASCIULLI R; GELMETTI V; GUERRIERO R; MACIOCE G; LIBERATORE C; BARBERI T; MARIANI G; PELICCI PG; PESCHLE C
    TERMINAL MEGAKARYOCYTIC DIFFERENTIATION OF TF-1 CELLS IS INDUCED BY PHORBOL ESTERS AND THROMBOPOIETIN AND IS BLOCKED BY EXPRESSION OF PML RAR-ALPHA FUSION PROTEIN/
    Leukemia
    
    U. Testa et al., "TERMINAL MEGAKARYOCYTIC DIFFERENTIATION OF TF-1 CELLS IS INDUCED BY PHORBOL ESTERS AND THROMBOPOIETIN AND IS BLOCKED BY EXPRESSION OF PML RAR-ALPHA FUSION PROTEIN/", Leukemia, 12(4), 1998, pp. 563-570
44. TONG JH; FANT X; DUPREZ E; BENOIT G; UPHOFF CC; DREXLER HG; PLA JC; LOFVENBERG E; LANOTTE M
    EXPRESSION PATTERNS OF THE JEM-1 GENE IN NORMAL AND TUMOR-CELLS - UBIQUITY CONTRASTING WITH A FAINT, BUT RETINOID-INDUCED, MESSENGER-RNA EXPRESSION IN PROMYELOCYTIC NB4 CELLS
    Leukemia
    
    J.H. Tong et al., "EXPRESSION PATTERNS OF THE JEM-1 GENE IN NORMAL AND TUMOR-CELLS - UBIQUITY CONTRASTING WITH A FAINT, BUT RETINOID-INDUCED, MESSENGER-RNA EXPRESSION IN PROMYELOCYTIC NB4 CELLS", Leukemia, 12(11), 1998, pp. 1733-1740
45. ALCALAY M; TOMASSONI L; COLOMBO E; STOLDT S; GRIGNANI F; FAGIOLI M; SZEKELY L; HELIN K; PELICCI PG
    THE PROMYELOCYTIC LEUKEMIA GENE-PRODUCT (PML) FORMS STABLE COMPLEXES WITH THE RETINOBLASTOMA PROTEIN
    Molecular and cellular biology
    
    M. Alcalay et al., "THE PROMYELOCYTIC LEUKEMIA GENE-PRODUCT (PML) FORMS STABLE COMPLEXES WITH THE RETINOBLASTOMA PROTEIN", Molecular and cellular biology, 18(2), 1998, pp. 1084-1093
46. VALLIAN S; CHIN KV; CHANG KS
    THE PROMYELOCYTIC LEUKEMIA PROTEIN INTERACTS WITH SP1 AND INHIBITS ITS TRANSACTIVATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR PROMOTER
    Molecular and cellular biology (Print)
    
    S. Vallian et al., "THE PROMYELOCYTIC LEUKEMIA PROTEIN INTERACTS WITH SP1 AND INHIBITS ITS TRANSACTIVATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR PROMOTER", Molecular and cellular biology (Print), 18(12), 1998, pp. 7147-7156
47. WANG ZG; DELVA L; GABOLI M; RIVI R; GIORGIO M; CORDONCARDO C; GROSVELD F; PANDOLFI PP
    ROLE OF PML IN CELL-GROWTH AND THE RETINOIC ACID PATHWAY
    Science
    
    Z.G. Wang et al., "ROLE OF PML IN CELL-GROWTH AND THE RETINOIC ACID PATHWAY", Science, 279(5356), 1998, pp. 1547-1551
48. LAMORTE VJ; DYCK JA; OCHS RL; EVANS RM
    LOCALIZATION OF NASCENT RNA AND CREB BINDING-PROTEIN WITH THE PML-CONTAINING NUCLEAR-BODY
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    V.J. Lamorte et al., "LOCALIZATION OF NASCENT RNA AND CREB BINDING-PROTEIN WITH THE PML-CONTAINING NUCLEAR-BODY", Proceedings of the National Academy of Sciences of the United Statesof America, 95(9), 1998, pp. 4991-4996
49. DAY PM; RODEN RBS; LOWY DR; SCHILLER JT
    THE PAPILLOMAVIRUS MINOR CAPSID PROTEIN, L2, INDUCES LOCALIZATION OF THE MAJOR CAPSID PROTEIN, L1, AND THE VIRAL TRANSCRIPTION REPLICATION PROTEIN, E2, TO PML ONCOGENIC DOMAINS/
    Journal of virology
    
    P.M. Day et al., "THE PAPILLOMAVIRUS MINOR CAPSID PROTEIN, L2, INDUCES LOCALIZATION OF THE MAJOR CAPSID PROTEIN, L1, AND THE VIRAL TRANSCRIPTION REPLICATION PROTEIN, E2, TO PML ONCOGENIC DOMAINS/", Journal of virology, 72(1), 1998, pp. 142-150
50. CAO TY; DUPREZ E; BORDEN KLB; FREEMONT PS; ETKIN LD
    RET FINGER PROTEIN IS A NORMAL COMPONENT OF PML NUCLEAR-BODIES AND INTERACTS DIRECTLY WITH PML
    Journal of Cell Science
    
    T.Y. Cao et al., "RET FINGER PROTEIN IS A NORMAL COMPONENT OF PML NUCLEAR-BODIES AND INTERACTS DIRECTLY WITH PML", Journal of Cell Science, 111, 1998, pp. 1319-1329
51. IMAIZUMI M; SUZUKI H; YOSHINARI M; SATO A; SAITO T; SUGAWARA A; TSUCHIYA S; HATAE Y; FUJIMOTO T; KAKIZUKA A; KONNO T; IINUMA K
    MUTATIONS IN THE E-DOMAIN OF RAR-ALPHA PORTION OF THE PML RAR-ALPHA CHIMERIC GENE MAY CONFER CLINICAL RESISTANCE TO ALL-TRANS-RETINOIC ACIDIN ACUTE PROMYELOCYTIC LEUKEMIA/
    Blood
    
    M. Imaizumi et al., "MUTATIONS IN THE E-DOMAIN OF RAR-ALPHA PORTION OF THE PML RAR-ALPHA CHIMERIC GENE MAY CONFER CLINICAL RESISTANCE TO ALL-TRANS-RETINOIC ACIDIN ACUTE PROMYELOCYTIC LEUKEMIA/", Blood, 92(2), 1998, pp. 374-382
52. LABRECQUE J; ALLAN D; CHAMBON P; ISCOVE NN; LOHNES D; HOANG T
    IMPAIRED GRANULOCYTIC DIFFERENTIATION IN-VITRO IN HEMATOPOIETIC-CELLSLACKING RETINOIC ACID RECEPTOR-ALPHA-1 AND RECEPTOR-GAMMA
    Blood
    
    J. Labrecque et al., "IMPAIRED GRANULOCYTIC DIFFERENTIATION IN-VITRO IN HEMATOPOIETIC-CELLSLACKING RETINOIC ACID RECEPTOR-ALPHA-1 AND RECEPTOR-GAMMA", Blood, 92(2), 1998, pp. 607-615
53. SAMOSZUK MK; TYNAN W; SALLASH G; NASR S; MONCZAK Y; MILLER WH
    AN IMMUNOFLUORESCENT ASSAY FOR ACUTE PROMYELOCYTIC LEUKEMIA-CELLS
    AJCP. American journal of clinical pathology
    
    M.K. Samoszuk et al., "AN IMMUNOFLUORESCENT ASSAY FOR ACUTE PROMYELOCYTIC LEUKEMIA-CELLS", AJCP. American journal of clinical pathology, 109(2), 1998, pp. 205-210
54. WELLS RA; CATZAVELOS C; KAMELREID S
    FUSION OF RETINOIC ACID RECEPTOR-ALPHA TO NUMA, THE NUCLEAR MITOTIC APPARATUS PROTEIN, BY A VARIANT TRANSLOCATION IN ACUTE PROMYELOCYTIC LEUKEMIA
    Nature genetics
    
    R.A. Wells et al., "FUSION OF RETINOIC ACID RECEPTOR-ALPHA TO NUMA, THE NUCLEAR MITOTIC APPARATUS PROTEIN, BY A VARIANT TRANSLOCATION IN ACUTE PROMYELOCYTIC LEUKEMIA", Nature genetics, 17(1), 1997, pp. 109-113
55. BIESALSKI HK
    BIOAVAILABILITY OF VITAMIN-A
    European journal of clinical nutrition
    
    H.K. Biesalski, "BIOAVAILABILITY OF VITAMIN-A", European journal of clinical nutrition, 51, 1997, pp. 71-75
56. SITTERLIN D; TIOLLAIS P; TRANSY C
    THE RAR-ALPHA-PLZF CHIMERA ASSOCIATED WITH ACUTE PROMYELOCYTIC LEUKEMIA HAS RETAINED A SEQUENCE-SPECIFIC DNA-BINDING DOMAIN
    Oncogene
    
    D. Sitterlin et al., "THE RAR-ALPHA-PLZF CHIMERA ASSOCIATED WITH ACUTE PROMYELOCYTIC LEUKEMIA HAS RETAINED A SEQUENCE-SPECIFIC DNA-BINDING DOMAIN", Oncogene, 14(9), 1997, pp. 1067-1074
57. GOGINENI SK; SHAH HO; CHESTER M; LIN JH; GARRISON M; ALIDINA A; BAYANI E; VERMA RS
    VARIANT COMPLEX TRANSLOCATIONS INVOLVING CHROMOSOME-1, CHROMOSOME-9, CHROMOSOME-9, CHROMOSOME-15 AND CHROMOSOME-17 IN ACUTE PROMYELOCYTIC LEUKEMIA WITHOUT RAR-ALPHA PML GENE FUSION REARRANGEMENT/
    Leukemia
    
    S.K. Gogineni et al., "VARIANT COMPLEX TRANSLOCATIONS INVOLVING CHROMOSOME-1, CHROMOSOME-9, CHROMOSOME-9, CHROMOSOME-15 AND CHROMOSOME-17 IN ACUTE PROMYELOCYTIC LEUKEMIA WITHOUT RAR-ALPHA PML GENE FUSION REARRANGEMENT/", Leukemia, 11(4), 1997, pp. 514-518
58. KITAMURA K; KIYOI H; YOSHIDA H; SAITO H; OHNO R; NAOE T
    MUTANT AF-2 DOMAIN OF PML-RAR-ALPHA IN RETINOIC ACID-RESISTANT NB4 CELLS - DIFFERENTIATION-INDUCED BY RA IS TRIGGERED DIRECTLY THROUGH PML-RAR-ALPHA AND ITS DOWN-REGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    K. Kitamura et al., "MUTANT AF-2 DOMAIN OF PML-RAR-ALPHA IN RETINOIC ACID-RESISTANT NB4 CELLS - DIFFERENTIATION-INDUCED BY RA IS TRIGGERED DIRECTLY THROUGH PML-RAR-ALPHA AND ITS DOWN-REGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 11(11), 1997, pp. 1950-1956
59. NASONBURCHENAL K; MAERZ W; ALBANELL J; ALLOPENNA J; MARTIN P; MOORE MAS; DMITROVSKY E
    COMMON DEFECTS OF DIFFERENT RETINOIC ACID-RESISTANT PROMYELOCYTIC LEUKEMIA-CELLS ARE PERSISTENT TELOMERASE ACTIVITY AND NUCLEAR-BODY DISORGANIZATION
    Differentiation
    
    K. Nasonburchenal et al., "COMMON DEFECTS OF DIFFERENT RETINOIC ACID-RESISTANT PROMYELOCYTIC LEUKEMIA-CELLS ARE PERSISTENT TELOMERASE ACTIVITY AND NUCLEAR-BODY DISORGANIZATION", Differentiation, 61(5), 1997, pp. 321-331
60. SZOSTECKI C; GULDNER HH; WILL H
    AUTOANTIBODIES AGAINST NUCLEAR DOTS IN PRIMARY BILIARY-CIRRHOSIS
    Seminars in liver disease
    
    C. Szostecki et al., "AUTOANTIBODIES AGAINST NUCLEAR DOTS IN PRIMARY BILIARY-CIRRHOSIS", Seminars in liver disease, 17(1), 1997, pp. 71-78
61. MU ZM; LE XF; VALLIAN S; GLASSMAN AB; CHANG KS
    STABLE OVEREXPRESSION OF PML ALTERS REGULATION OF CELL-CYCLE PROGRESSION IN HELA-CELLS
    Carcinogenesis
    
    Z.M. Mu et al., "STABLE OVEREXPRESSION OF PML ALTERS REGULATION OF CELL-CYCLE PROGRESSION IN HELA-CELLS", Carcinogenesis, 18(11), 1997, pp. 2063-2069
62. BROWN D; KOGAN S; LAGASSE E; WEISSMAN I; ALCALAY M; PELICCI PG; ATWATER S; BISHOP JM
    A PMLRAR-ALPHA TRANSGENE INITIATES MURINE ACUTE PROMYELOCYTIC LEUKEMIA
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    D. Brown et al., "A PMLRAR-ALPHA TRANSGENE INITIATES MURINE ACUTE PROMYELOCYTIC LEUKEMIA", Proceedings of the National Academy of Sciences of the United Statesof America, 94(6), 1997, pp. 2551-2556
63. KOKEN MHM; REID A; QUIGNON F; CHELBIALIX MK; DAVIES JM; KABAROWSKI JHS; ZHU J; DONG S; CHEN SJ; CHEN Z; TAN CC; LICHT J; WAXMAN S; DETHE H; ZELENT A
    LEUKEMIA-ASSOCIATED RETINOIC ACID RECEPTOR-ALPHA FUSION PARTNERS, PMLAND PLZF, HETERODIMERIZE AND COLOCALIZE TO NUCLEAR-BODIES
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    M.H.M. Koken et al., "LEUKEMIA-ASSOCIATED RETINOIC ACID RECEPTOR-ALPHA FUSION PARTNERS, PMLAND PLZF, HETERODIMERIZE AND COLOCALIZE TO NUCLEAR-BODIES", Proceedings of the National Academy of Sciences of the United Statesof America, 94(19), 1997, pp. 10255-10260
64. HONG SH; DAVID G; WONG CW; DEJEAN A; PRIVALSKY ML
    SMRT COREPRESSOR INTERACTS WITH PLZF AND WITH THE PML-RETINOIC ACID RECEPTOR-ALPHA (RAR-ALPHA) AND PLZF-RAR-ALPHA ONCOPROTEINS ASSOCIATED WITH ACUTE PROMYELOCYTIC LEUKEMIA
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    S.H. Hong et al., "SMRT COREPRESSOR INTERACTS WITH PLZF AND WITH THE PML-RETINOIC ACID RECEPTOR-ALPHA (RAR-ALPHA) AND PLZF-RAR-ALPHA ONCOPROTEINS ASSOCIATED WITH ACUTE PROMYELOCYTIC LEUKEMIA", Proceedings of the National Academy of Sciences of the United Statesof America, 94(17), 1997, pp. 9028-9033
65. HE LZ; TRIBIOLI C; RIVI R; PERUZZI D; PELICCI PG; SOARES V; CATTORETTI G; PANDOLFI PP
    ACUTE-LEUKEMIA WITH PROMYELOCYTIC FEATURES IN PML RAR-ALPHA TRANSGENIC MICE/
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    L.Z. He et al., "ACUTE-LEUKEMIA WITH PROMYELOCYTIC FEATURES IN PML RAR-ALPHA TRANSGENIC MICE/", Proceedings of the National Academy of Sciences of the United Statesof America, 94(10), 1997, pp. 5302-5307
66. KALANTRY S; DELVA L; GABOLI M; GANDINI D; GIORGIO M; HAWE N; HE LZ; PERUZZI D; RIVI R; TRIBIOLI C; WANG ZG; ZHANG H; PANDOLFI PP
    GENE REARRANGEMENTS IN THE MOLECULAR PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA
    Journal of cellular physiology
    
    S. Kalantry et al., "GENE REARRANGEMENTS IN THE MOLECULAR PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA", Journal of cellular physiology, 173(2), 1997, pp. 288-296
67. STERNSDORF T; JENSEN K; WILL H
    EVIDENCE FOR COVALENT MODIFICATION OF THE NUCLEAR DOT-ASSOCIATED PROTEINS PML AND SP100 BY PIC1 SUMO-1/
    The Journal of cell biology
    
    T. Sternsdorf et al., "EVIDENCE FOR COVALENT MODIFICATION OF THE NUCLEAR DOT-ASSOCIATED PROTEINS PML AND SP100 BY PIC1 SUMO-1/", The Journal of cell biology, 139(7), 1997, pp. 1621-1634
68. STERNSDORF T; JENSEN K; ZUCHNER D; WILL H
    CELLULAR-LOCALIZATION, EXPRESSION, AND STRUCTURE OF THE NUCLEAR DOT PROTEIN-52
    The Journal of cell biology
    
    T. Sternsdorf et al., "CELLULAR-LOCALIZATION, EXPRESSION, AND STRUCTURE OF THE NUCLEAR DOT PROTEIN-52", The Journal of cell biology, 138(2), 1997, pp. 435-448
69. LI JY; ENGLISH MA; BALL HJ; YEYATI PL; WAXMAN S; LICHT JD
    SEQUENCE-SPECIFIC DNA-BINDING AND TRANSCRIPTIONAL REGULATION BY THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER PROTEIN
    The Journal of biological chemistry
    
    J.Y. Li et al., "SEQUENCE-SPECIFIC DNA-BINDING AND TRANSCRIPTIONAL REGULATION BY THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER PROTEIN", The Journal of biological chemistry, 272(36), 1997, pp. 22447-22455
70. KAMEI H
    CYSTINE STARVATION INDUCES REVERSIBLE LARGE-BODY FORMATION FROM NUCLEAR-BODIES IN T24 CELLS
    Experimental cell research
    
    H. Kamei, "CYSTINE STARVATION INDUCES REVERSIBLE LARGE-BODY FORMATION FROM NUCLEAR-BODIES IN T24 CELLS", Experimental cell research, 237(1), 1997, pp. 207-216
71. BROOKS SC; STURGILL R; CHOI J; YEN A
    AN RXR-SELECTIVE ANALOG ATTENUATES THE RAR-ALPHA-SELECTIVE ANALOG-INDUCED DIFFERENTIATION AND NON-G(1)-RESTRICTED GROWTH ARREST OF NB4 CELLS
    Experimental cell research
    
    S.C. Brooks et al., "AN RXR-SELECTIVE ANALOG ATTENUATES THE RAR-ALPHA-SELECTIVE ANALOG-INDUCED DIFFERENTIATION AND NON-G(1)-RESTRICTED GROWTH ARREST OF NB4 CELLS", Experimental cell research, 234(2), 1997, pp. 259-269
72. CHIH DY; CHUMAKOV AM; PARK DJ; SILLA AG; KOEFFLER HP
    MODULATION OF MESSENGER-RNA EXPRESSION OF A NOVEL HUMAN MYELOID-SELECTIVE CCAAT ENHANCER BINDING-PROTEIN GENE (C/EBP-EPSILON)/
    Blood
    
    D.Y. Chih et al., "MODULATION OF MESSENGER-RNA EXPRESSION OF A NOVEL HUMAN MYELOID-SELECTIVE CCAAT ENHANCER BINDING-PROTEIN GENE (C/EBP-EPSILON)/", Blood, 90(8), 1997, pp. 2987-2994
73. BENEDETTI L; LEVIN AA; SCICCHITANO BM; GRIGNANI F; ALLENBY G; DIVERIO D; LOCOCO F; AVVISATI G; RUTHARDT M; ADAMO S; PELICCI PG; NERVI C
    CHARACTERIZATION OF THE RETINOID-BINDING PROPERTIES OF THE MAJOR FUSION PRODUCTS PRESENT IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS
    Blood
    
    L. Benedetti et al., "CHARACTERIZATION OF THE RETINOID-BINDING PROPERTIES OF THE MAJOR FUSION PRODUCTS PRESENT IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS", Blood, 90(3), 1997, pp. 1175-1185
74. LI YP; ANDERSEN J; ZELENT A; RAO S; PAIETTA E; TALLMAN MS; WIERNIK PH; GALLAGHER RE
    RAR-ALPHA-1 RAR-ALPHA-2-PML MESSENGER-RNA EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS - A MOLECULAR AND LABORATORY-CLINICAL CORRELATIVE STUDY/
    Blood
    
    Y.P. Li et al., "RAR-ALPHA-1 RAR-ALPHA-2-PML MESSENGER-RNA EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS - A MOLECULAR AND LABORATORY-CLINICAL CORRELATIVE STUDY/", Blood, 90(1), 1997, pp. 306-312
75. GRISOLANO JL; WESSELSCHMIDT RL; PELICCI PG; LEY TJ
    ALTERED MYELOID DEVELOPMENT AND ACUTE-LEUKEMIA IN TRANSGENIC MICE EXPRESSING PML-RAR-ALPHA UNDER CONTROL OF CATHEPSIN-G REGULATORY SEQUENCES
    Blood
    
    J.L. Grisolano et al., "ALTERED MYELOID DEVELOPMENT AND ACUTE-LEUKEMIA IN TRANSGENIC MICE EXPRESSING PML-RAR-ALPHA UNDER CONTROL OF CATHEPSIN-G REGULATORY SEQUENCES", Blood, 89(2), 1997, pp. 376-387
76. CHEN Z; TONG JH; DONG S; ZHU J; WANG ZY; CHEN SJ
    RETINOIC ACID REGULATORY PATHWAYS, CHROMOSOMAL TRANSLOCATIONS, AND ACUTE PROMYELOCYTIC LEUKEMIA
    Genes, chromosomes & cancer
    
    Z. Chen et al., "RETINOIC ACID REGULATORY PATHWAYS, CHROMOSOMAL TRANSLOCATIONS, AND ACUTE PROMYELOCYTIC LEUKEMIA", Genes, chromosomes & cancer, 15(3), 1996, pp. 147-156
77. VISANI G; MANFROI S; TOSI P; MARTINELLI G
    ALL-TRANS-RETINOIC ACID AND PSEUDOTUMOR CEREBRI
    Leukemia & lymphoma
    
    G. Visani et al., "ALL-TRANS-RETINOIC ACID AND PSEUDOTUMOR CEREBRI", Leukemia & lymphoma, 23(5-6), 1996, pp. 437-442
78. MU ZM; LE XF; GLASSMAN AB; CHANG KS
    THE BIOLOGIC FUNCTION OF PML AND ITS ROLE IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia & lymphoma
    
    Z.M. Mu et al., "THE BIOLOGIC FUNCTION OF PML AND ITS ROLE IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia & lymphoma, 23(3-4), 1996, pp. 277
79. DOUCAS V; ISHOV AM; ROMO A; JUGUILON H; WEITZMAN MD; EVANS RM; MAUL GG
    ADENOVIRUS REPLICATION IS COUPLED WITH THE DYNAMIC PROPERTIES OF THE PML NUCLEAR-STRUCTURE
    Genes & development
    
    V. Doucas et al., "ADENOVIRUS REPLICATION IS COUPLED WITH THE DYNAMIC PROPERTIES OF THE PML NUCLEAR-STRUCTURE", Genes & development, 10(2), 1996, pp. 196-207
80. KANE JR; HEAD DR; BALAZS L; HULSHOF MG; MOTRONI TA; RAIMONDI SC; CARROLL AJ; BEH FG; KRANCE RA; SHURTLEFF SA; DOWNING JR
    MOLECULAR ANALYSIS OF THE PML RAR-ALPHA CHIMERIC GENE IN PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA/
    Leukemia
    
    J.R. Kane et al., "MOLECULAR ANALYSIS OF THE PML RAR-ALPHA CHIMERIC GENE IN PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA/", Leukemia, 10(8), 1996, pp. 1296-1302
81. WELLS RA; HUMMEL JL; DEKOVEN A; ZIPURSKY A; KIRBY M; DUBE I; KAMELREID S
    A NEW VARIANT TRANSLOCATION IN ACUTE PROMYELOCYTIC LEUKEMIA - MOLECULAR CHARACTERIZATION AND CLINICAL CORRELATION
    Leukemia
    
    R.A. Wells et al., "A NEW VARIANT TRANSLOCATION IN ACUTE PROMYELOCYTIC LEUKEMIA - MOLECULAR CHARACTERIZATION AND CLINICAL CORRELATION", Leukemia, 10(4), 1996, pp. 735-740
82. GRIMWADE D; HOWE K; LANGABEER S; BURNETT A; GOLDSTONE A; SOLOMON E
    MINIMAL RESIDUAL DISEASE DETECTION IN ACUTE PROMYELOCYTIC LEUKEMIA BYREVERSE-TRANSCRIPTASE PCR - EVALUATION OF PML-RAR-ALPHA AND RAR-ALPHA-PML ASSESSMENT IN PATIENTS WHO ULTIMATELY RELAPSE
    Leukemia
    
    D. Grimwade et al., "MINIMAL RESIDUAL DISEASE DETECTION IN ACUTE PROMYELOCYTIC LEUKEMIA BYREVERSE-TRANSCRIPTASE PCR - EVALUATION OF PML-RAR-ALPHA AND RAR-ALPHA-PML ASSESSMENT IN PATIENTS WHO ULTIMATELY RELAPSE", Leukemia, 10(1), 1996, pp. 61-66
83. SEALE J; DELVA L; RENESTO P; BALITRAND N; DOMBRET H; SCROBOHACI ML; DEGOS L; PAUL P; CHOMIENNE C
    ALL-TRANS-RETINOIC ACID RAPIDLY DECREASES CATHEPSIN-G SYNTHESIS AND MESSENGER-RNA EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    J. Seale et al., "ALL-TRANS-RETINOIC ACID RAPIDLY DECREASES CATHEPSIN-G SYNTHESIS AND MESSENGER-RNA EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 10(1), 1996, pp. 95-101
84. MILLER WH
    DIFFERENTIATION THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA - CLINICAL AND MOLECULAR-FEATURES
    Cancer investigation
    
    W.H. Miller, "DIFFERENTIATION THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA - CLINICAL AND MOLECULAR-FEATURES", Cancer investigation, 14(2), 1996, pp. 142-150
85. DENNY CT
    GENE REARRANGEMENTS IN EWINGS-SARCOMA
    Cancer investigation
    
    C.T. Denny, "GENE REARRANGEMENTS IN EWINGS-SARCOMA", Cancer investigation, 14(1), 1996, pp. 83-88
86. PANDOLFI PP
    PML, PLZF AND NPM GENES IN THE MOLECULAR PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA
    Haematologica
    
    P.P. Pandolfi, "PML, PLZF AND NPM GENES IN THE MOLECULAR PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA", Haematologica, 81(5), 1996, pp. 472-482
87. DOUCAS V; EVANS RM
    THE PML NUCLEAR COMPARTMENT AND CANCER
    Biochimica et biophysica acta, CR. Reviews on cancer
    
    V. Doucas e R.M. Evans, "THE PML NUCLEAR COMPARTMENT AND CANCER", Biochimica et biophysica acta, CR. Reviews on cancer, 1288(3), 1996, pp. 25-29
88. HSU SL; LIN HM; CHOU CK
    SUPPRESSION OF THE TUMORIGENICITY OF HUMAN HEPATOMA HEP3B CELLS BY LONG-TERM RETINOIC ACID TREATMENT
    Cancer letters
    
    S.L. Hsu et al., "SUPPRESSION OF THE TUMORIGENICITY OF HUMAN HEPATOMA HEP3B CELLS BY LONG-TERM RETINOIC ACID TREATMENT", Cancer letters, 99(1), 1996, pp. 79-85
89. SCHMITT K; ZOUBEK A; SCHWARZ R; TULZER G; KOLLER E; KRIEGER O; LUTZ D; GADNER H
    ALL-TRANS-RETINOIC ACID AND SHOUT-TIME, HIGH-DOSE CYTARABINE IN 2 CHILDREN WITH ACUTE PROMYELOCYTIC LEUKEMIA
    Medical and pediatric oncology
    
    K. Schmitt et al., "ALL-TRANS-RETINOIC ACID AND SHOUT-TIME, HIGH-DOSE CYTARABINE IN 2 CHILDREN WITH ACUTE PROMYELOCYTIC LEUKEMIA", Medical and pediatric oncology, 26(4), 1996, pp. 254-257
90. DONG S; ZHU J; REID A; STRUTT P; GUIDEZ F; ZHONG HJ; WANG ZY; LICHT J; WAXMAN S; CHOMIENNE C; CHEN Z; ZELENT A; CHEN SJ
    AMINO-TERMINAL PROTEIN-PROTEIN INTERACTION MOTIF (POZ-DOMAIN) IS RESPONSIBLE FOR ACTIVITIES OF THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER RETINOIC ACID RECEPTOR-ALPHA FUSION PROTEIN
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    S. Dong et al., "AMINO-TERMINAL PROTEIN-PROTEIN INTERACTION MOTIF (POZ-DOMAIN) IS RESPONSIBLE FOR ACTIVITIES OF THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER RETINOIC ACID RECEPTOR-ALPHA FUSION PROTEIN", Proceedings of the National Academy of Sciences of the United Statesof America, 93(8), 1996, pp. 3624-3629
91. EARLY E; MOORE MAS; KAKIZUKA A; NASONBURCHENAL K; MARTIN P; EVANS RM; DMITROVSKY E
    TRANSGENIC EXPRESSION OF PML RAR-ALPHA IMPAIRS MYELOPOIESIS/
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    E. Early et al., "TRANSGENIC EXPRESSION OF PML RAR-ALPHA IMPAIRS MYELOPOIESIS/", Proceedings of the National Academy of Sciences of the United Statesof America, 93(15), 1996, pp. 7900-7904
92. GROTZINGER T; JENSEN K; WILL H
    THE INTERFERON (IFN)-STIMULATED GENE SP100 PROMOTER CONTAINS AN IFN-GAMMA ACTIVATION SITE AND AN IMPERFECT IFN-STIMULATED RESPONSE ELEMENT WHICH MEDIATE TYPE-I IFN INDUCIBILITY
    The Journal of biological chemistry
    
    T. Grotzinger et al., "THE INTERFERON (IFN)-STIMULATED GENE SP100 PROMOTER CONTAINS AN IFN-GAMMA ACTIVATION SITE AND AN IMPERFECT IFN-STIMULATED RESPONSE ELEMENT WHICH MEDIATE TYPE-I IFN INDUCIBILITY", The Journal of biological chemistry, 271(41), 1996, pp. 25253-25260
93. LE XF; YANG P; CHANG KS
    ANALYSIS OF THE GROWTH AND TRANSFORMATION SUPPRESSOR DOMAINS OF PROMYELOCYTIC LEUKEMIA GENE, PML
    The Journal of biological chemistry
    
    X.F. Le et al., "ANALYSIS OF THE GROWTH AND TRANSFORMATION SUPPRESSOR DOMAINS OF PROMYELOCYTIC LEUKEMIA GENE, PML", The Journal of biological chemistry, 271(1), 1996, pp. 130-135
94. ANDRE C; GUILLEMIN MC; ZHU J; KOKEN MHM; QUIGNON F; HERVE L; CHELBIALIX MK; DHUMEAUX D; WANG ZY; DEGOS L; CHEN Z; DETHE H
    THE PML AND PML RAR-ALPHA DOMAINS - FROM AUTOIMMUNITY TO MOLECULAR ONCOLOGY AND FROM RETINOIC ACID TO ARSENIC/
    Experimental cell research
    
    C. Andre et al., "THE PML AND PML RAR-ALPHA DOMAINS - FROM AUTOIMMUNITY TO MOLECULAR ONCOLOGY AND FROM RETINOIC ACID TO ARSENIC/", Experimental cell research, 229(2), 1996, pp. 253-260
95. KAMEI H
    REVERSIBLE LARGE-BODY FORMATION FROM NUCLEAR-BODIES UPON AMINO ACID(S) STARVATION IN T24 CELLS
    Experimental cell research
    
    H. Kamei, "REVERSIBLE LARGE-BODY FORMATION FROM NUCLEAR-BODIES UPON AMINO ACID(S) STARVATION IN T24 CELLS", Experimental cell research, 224(2), 1996, pp. 302-311
96. BHATIA M; KIRKLAND JB; MECKLINGGILL KA
    1,25-DIHYDROXYVITAMIN D-3 PRIMES ACUTE PROMYELOCYTIC CELLS FOR TPA-INDUCED MONOCYTIC DIFFERENTIATION THROUGH BOTH PKC AND TYROSINE PHOSPHORYLATION CASCADES
    Experimental cell research
    
    M. Bhatia et al., "1,25-DIHYDROXYVITAMIN D-3 PRIMES ACUTE PROMYELOCYTIC CELLS FOR TPA-INDUCED MONOCYTIC DIFFERENTIATION THROUGH BOTH PKC AND TYROSINE PHOSPHORYLATION CASCADES", Experimental cell research, 222(1), 1996, pp. 61-69
97. GROTZINGER T; STERNSDORF T; JENSEN K; WILL H
    INTERFERON-MODULATED EXPRESSION OF GENES ENCODING THE NUCLEAR-DOT-ASSOCIATED PROTEINS SP100 AND PROMYELOCYTIC LEUKEMIA PROTEIN (PML)
    European journal of biochemistry
    
    T. Grotzinger et al., "INTERFERON-MODULATED EXPRESSION OF GENES ENCODING THE NUCLEAR-DOT-ASSOCIATED PROTEINS SP100 AND PROMYELOCYTIC LEUKEMIA PROTEIN (PML)", European journal of biochemistry, 238(2), 1996, pp. 554-560
98. YOSHIDA H; KITAMURA K; TANAKA K; OMURA S; MIYAZAKI T; HACHIYA T; OHNO R; NAOE T
    ACCELERATED DEGRADATION OF PML-RETINOIC ACID RECEPTOR-ALPHA (PML-RARA) ONCOPROTEIN BY ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA - POSSIBLE ROLE OF THE PROTEASOME PATHWAY
    Cancer research
    
    H. Yoshida et al., "ACCELERATED DEGRADATION OF PML-RETINOIC ACID RECEPTOR-ALPHA (PML-RARA) ONCOPROTEIN BY ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA - POSSIBLE ROLE OF THE PROTEASOME PATHWAY", Cancer research, 56(13), 1996, pp. 2945-2948
99. DIBONA E; MONTALDI A; GUERCINI N; ROSSI V; LUCIANO A; BIONDI A; RODEGHIERO F
    A (15-17)-TRANSLOCATION NOT ASSOCIATED WITH ACUTE PROMYELOCYTIC LEUKEMIA
    British Journal of Haematology
    
    E. Dibona et al., "A (15-17)-TRANSLOCATION NOT ASSOCIATED WITH ACUTE PROMYELOCYTIC LEUKEMIA", British Journal of Haematology, 95(4), 1996, pp. 706-709
100. MAEDA Y; HORIUCHI F; MIYATAKE J; SONO H; TATSUMI Y; URASE F; IRIMAJIRI K; HORIUCHI A
     INHIBITION OF GROWTH AND INDUCTION OF APOPTOSIS BY ALL-TRANS-RETINOICACID IN LYMPHOID-CELL LINES TRANSFECTED WITH THE PML RAR-ALPHA FUSIONGENE/
     British Journal of Haematology
     
     Y. Maeda et al., "INHIBITION OF GROWTH AND INDUCTION OF APOPTOSIS BY ALL-TRANS-RETINOICACID IN LYMPHOID-CELL LINES TRANSFECTED WITH THE PML RAR-ALPHA FUSIONGENE/", British Journal of Haematology, 93(4), 1996, pp. 973-976